FITC Anti-Human CD73 Antibody[ AD2]

FITC Anti-Human CD73 Antibody[ AD2]

Introducing the FITC Anti-Human CD73 Antibody [AD2], a highly advanced and meticulously developed product designed to cater to the specific needs of the scientific community. This antibody, labeled with FITC (Fluorescein Isothiocyanate), offers exceptional specificity and sensitivity in detecting and quantifying CD73 expression in human samples.

The FITC Anti-Human CD73 Antibody [AD2] is meticulously manufactured using cutting-edge techniques and state-of-the-art equipment, ensuring the highest level of quality and reliability. Its superior performance is attributed to the rigorous validation process it undergoes, guaranteeing accurate and reproducible results.

This antibody is specifically engineered to target CD73, a cell surface enzyme involved in the conversion of extracellular nucleotides into bioactive adenosine. By selectively binding to CD73, this antibody enables researchers to investigate its role in various biological processes, including immune response modulation, tumor progression, and inflammation.

The FITC labeling of this antibody allows for easy visualization and analysis of CD73 expression through flow cytometry or fluorescence microscopy. Its bright and stable fluorescence signal ensures precise identification and characterization of CD73-positive cells, facilitating comprehensive research and analysis.

Furthermore, the FITC Anti-Human CD73 Antibody [AD2] exhibits exceptional versatility, making it compatible with a wide range of applications, including immunohistochemistry, immunofluorescence, and western blotting. Its adaptability enables researchers to explore CD73 expression in diverse experimental settings, expanding the scope of scientific investigations.

In summary, the FITC Anti-Human CD73 Antibody [AD2] is an indispensable tool for researchers seeking to unravel the intricate mechanisms involving CD73. With its unparalleled specificity, sensitivity, and versatility, this antibody empowers scientists to delve deeper into the complexities of CD73 biology, paving the way for groundbreaking discoveries and advancements in the field of biomedical research.